Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001193125-25-314736 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-12-10 | 2025-12-08+ | WVE | Moran Kyle | CFO | M - OptEx | $5.20 | +296.0K | 189.2K | New | +$1.54M |
| DMT | 2025-12-10 | 2025-12-08+ | WVE | Moran Kyle | CFO | S - Sale+OE | $15.78 | -260.0K | 89.2K | -74% | -$4.10M |
| DMT | 2025-12-10 | 2025-12-08+ | WVE | Moran Kyle | CFO | A - Grant | $0.00 | -296.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-12-08 | M | A | 60,000 | $2.83 | 149,218 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-12-09 | S | D | 50,000 | $20.03 | 90,365 | D | — | — | (F6) The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $20.00 to $20.22 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. (F7) Includes 1,147 ordinary shares acquired on July 14, 2025, under the issuer's 2019 Employee Share Purchase Plan. |
| 3 | Common | Ordinary Shares | 2025-12-09 | M | A | 50,000 | $10.48 | 139,218 | D | — | — | |
| 4 | Common | Ordinary Shares | 2025-12-09 | S | D | 36 | $20.25 | 89,218 | D | — | — | (F6) The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $20.00 to $20.22 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Ordinary Shares | 2025-12-09 | M | A | 36,000 | $8.17 | 125,218 | D | — | — | |
| 6 | Common | Ordinary Shares | 2025-12-08 | S | D | 60,000 | $13.20 | 89,218 | D | — | — | |
| 7 | Common | Ordinary Shares | 2025-12-08 | M | A | 50,000 | $4.75 | 139,218 | D | — | — | |
| 8 | Common | Ordinary Shares | 2025-12-08 | S | D | 50,000 | $13.20 | 89,218 | D | — | — | |
| 9 | Common | Ordinary Shares | 2025-12-08 | S | D | 50,000 | $15.00 | 139,218 | D | — | — | (F4) The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $15.00 to $15.045 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 10 | Common | Ordinary Shares | 2025-12-08 | M | A | 100,000 | $3.14 | 189,218 | D | — | — | |
| 11 | Common | Ordinary Shares | 2025-12-08 | S | D | 50,000 | $18.00 | 89,218 | D | — | — | |
| 12 | Derivative | Share Option (right to buy) | 2025-12-08 | A | D | 60,000 | $0.00 | 0 | D | $2.83 · — to 2032-07-25 | 60,000 Ordinary Shares | (F2) These share options are fully vested. |
| 13 | Derivative | Share Option (right to buy) | 2025-12-08 | A | D | 100,000 | $0.00 | 75,000 | D | $3.14 · — to 2032-01-01 | 100,000 Ordinary Shares | (F3) The share option represented a right to purchase a total of 175,000 ordinary shares that vest as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026. |
| 14 | Derivative | Share Option (right to buy) | 2025-12-08 | A | D | 50,000 | $0.00 | 222,700 | D | $4.75 · — to 2033-02-17 | 50,000 Ordinary Shares | (F5) The share option represented a right to purchase a total of 272,200 ordinary shares that vest as to 25% of the shares on February 17, 2024 and vests as to an additional 6.25% of the shares quarterly thereafter until February 17, 2027. |
| 15 | Derivative | Share Option (right to buy) | 2025-12-09 | A | D | 36,000 | $0.00 | 0 | D | $8.17 · — to 2030-03-03 | 36,000 Ordinary Shares | (F2) These share options are fully vested. |
| 16 | Derivative | Share Option (right to buy) | 2025-12-09 | A | D | 50,000 | $0.00 | 0 | D | $10.48 · — to 2031-02-01 | 50,000 Ordinary Shares | (F2) These share options are fully vested. |